Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Bevacizumab and VEGF on Platelet Aggregation

NCT00898794 is registered in ClinicalTrials.gov with Kantonsspital Graubuenden as lead sponsor.

NCT NCT00898794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00898794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Bevacizumab and VEGF on Platelet Aggregation
Lead sponsor
Kantonsspital Graubuenden
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2007
Completion date
Not reported
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific, unspecified childhood solid tumor, protocol specific